Riccardo Braglia - 22 Sep 2021 Form 3 Insider Report for Thorne Healthtech, Inc.

Role
Director, 10%+ Owner
Signature
/s/ Scott Wheeler, under power of attorney
Issuer symbol
N/A
Transactions as of
22 Sep 2021
Net transactions value
$0
Form type
3
Filing time
22 Sep 2021, 18:18:22 UTC
Next filing
29 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding THRN Class A Common Stock 5,396,960 22 Sep 2021 See Footnote F1, F2
holding THRN Class B Common Stock 27,590 22 Sep 2021 See Footnote F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding THRN Class A Common Stock Warrant (Right to buy) 22 Sep 2021 Class A Common Stock 453,455 $6.74 See Footnote F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately prior to the completion of the Issuer's initial public offering of Common Stock, the Class A Common Stock shall be re-named Common Stock.
F2 The securities are directly held by ELUS Holdings Corporation ("ELUS"). The Reporting Person serves as Chairman of the Board of ELUS and as Chief Executive Officer and a member of the Board of Directors of ELUS' ultimate parent company, Helsinn Holding SA.
F3 Each share of non-voting Class B Common Stock shall be converted into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock.
F4 All of the shares subject to the warrant are fully vested and exercisable as of the date hereof.

Remarks:

Exhibit 24 - Power of Attorney